---
schema_version: "secwatch.filing_event.v1"
accession: "0001708599-25-000048"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2025-04-29T23:59:59+00:00"
generated_at: "2026-05-23T03:56:23.584541+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Serina Therapeutics enters ATM facility for up to $13.3M common stock sale

## Summary
- Entered Capital on Demand Sales Agreement with JonesTrading for at-the-market offering of up to $13,270,500 in common stock.
- JonesTrading will receive 3.0% commission on gross sales; company also reimburses up to $50,000 in legal expenses.
- Sales will occur on NYSE American or other trading markets at the company's direction; no minimum obligation to sell.
- Updated description of capital stock filed as Exhibit 4.1 to reflect recent certificate of designations.
- Proceeds intended for general corporate purposes; offering registered on Form S-3 (File No. 333-286340).

## SEC filing metadata
- accession: 0001708599-25-000048
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2025-04-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000170859925000048/0001708599-25-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000170859925000048/ser-20250425.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001708599-25-000048
- JSON: https://secwatch.observer/filing/0001708599-25-000048.json
- Plain text: https://secwatch.observer/filing/0001708599-25-000048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.